OVID vs ZBH · rev $733.0K vs P/E 23, rev $8.23B
Ovid Therapeutics Inc (OVID) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
Latest reported ZBH revenue for 2025-12-31 was $8.23B. Net income was $705.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
OVID currently screens at market cap $23.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the OVID and ZBH stock pages for the full models.
Not investment advice.